Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Experimental & Molecular Medicine ; : 35-42, 2008.
Artículo en Inglés | WPRIM | ID: wpr-219395

RESUMEN

In order to develop an anti-human TNF-alpha mAb, mice were immunized with recombinant human TNF-alpha. A murine mAb, TSK114, which showed the highest binding activity for human TNF-alpha was selected and characterized. TSK114 specifically bound to human TNF-alpha without cross-reactivity with the homologous murine TNF-alpha and human TNF-beta TSK114 was found to be of IgG1 isotype with kappa light chain. The nucleotide sequences of the variable regions of TSK114 heavy and light chains were determined and analyzed for the usage of gene families for the variable (V), diversity (D), and joining (J) segments. Kinetic analysis of TSK114 binding to human TNF-alpha by surface plasmon resonance technique revealed a binding affinity (KD) of ~5.3 pM, which is about 1,000- and 100-fold higher than those of clinically relevant infliximab (Remicade) and adalimumab (Humira) mAbs, respectively. TSK114 neutralized human TNF-alpha-mediated cytotoxicity in proportion to the concentration, exhibiting about 4-fold greater efficiency than those of infliximab and adalimumab in WEHI 164 cells used as an in vitro model system. These results suggest that TSK114 has the potential to be developed into a therapeutic TNF-alpha-neutralizing antibody with picomolar affinity.


Asunto(s)
Animales , Humanos , Ratones , Secuencia de Aminoácidos , Anticuerpos Monoclonales/química , Afinidad de Anticuerpos/inmunología , Especificidad de Anticuerpos , Secuencia de Bases , Western Blotting , Línea Celular , Citotoxicidad Inmunológica , Ensayo de Inmunoadsorción Enzimática , Región Variable de Inmunoglobulina/genética , Cinética , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Pruebas de Neutralización , Análisis de Secuencia de Proteína , Factor de Necrosis Tumoral alfa/inmunología
2.
Immune Network ; : 281-286, 2003.
Artículo en Coreano | WPRIM | ID: wpr-157395

RESUMEN

BACKGROUND: Hepatitis B virus (HBV) infection is one of the worldwide public health problem affecting about 300 million people. The envelope protein of HBV consists of three components known as preS1, preS2, and S antigen. According to the recent study, anti-HBs Ab showed effective neutralization ability against HBV from chronic hepatitis B and liver transplant patients, suggesting the possible development of therapeutic antibody. METHODS: Spleen cells immunized with S antigen of HBV were fused with myeloma cell line to obtain HBsAg specific monoclonal antibodies. High affinity antibodies against HBsAg (adr, ad and ay type) were selected by competitive ELISA method. Nucleotide sequence of the variable regions of monoclonal antibodies was analyzed by RT-PCR followed by conventional sequencing method. RESULTS: We produced 14 murine monoclonal antibodies which recognize S antigen of HBV. Two of them, A9-11 and C6-9 showed the highest affinity. The sequence analysis of A9-11 revealed that variable regions of the heavy chain and light chains are members of mouse heavy chain I (B) and light chain lambda 1, respectively. Likewise, the sequence analysis of C6-9 revealed that variable regions of the heavy chain and light chains are members of mouse heavy chain II (B) and light chain kappa 1, respectively. Neutralization assay showed that A9-11 and C6-9 effectively neutralize the HBV infection. CONCLUSION: These results suggest that A9-11 and C6-9 mouse monoclonal antibodies can be used for the development of therapeutic antibody for HBV infection.


Asunto(s)
Animales , Humanos , Ratones , Anticuerpos , Anticuerpos Monoclonales , Secuencia de Bases , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Antígenos de Superficie de la Hepatitis B , Virus de la Hepatitis B , Hepatitis B , Hepatitis B Crónica , Hepatitis , Hígado , Salud Pública , Análisis de Secuencia , Bazo
3.
Journal of Korean Neurosurgical Society ; : 417-424, 2001.
Artículo en Coreano | WPRIM | ID: wpr-168595

RESUMEN

OBJECTIVE: Adrenal medullary chromaffin cells are known to release analgesic substances such as opioides and catecholamines. Transplantation of them is a novel method that challenges current approaches in treating chronic pain. The transplantation of xenogeneic chromaffin cells into the central nervous system(CNS) supply antinociception in animals. In this study, we investigated the analgesic effects of rat adrenal medullary chromaffin cells transplanted into the CNS of the mouse. To study the antinociceptive efficacy of transplanted chromaffin cells, the survival of rat adrenal medullary chromaffin cells transplanted into the CNS of mouse was determined. METHODS: The adrenal medullary chromaffin cells isolated from rat were transplanted into the striatum of mouse. These cells were confirmed of the release of Met-enkephalin and Leu-enkephalin by HPLC, and immunoblots for tyrosine hydroxylase(TH). Two weeks after transplantation, we performed immunohistochemistry for TH to determine the survival of implanted cells and assessed pain sensitivity at the same time. RESULTS: The isolated rat adrenal medullary chromaffin cells were positive for anti-TH antibody and released Met-enkephalin and Leu-enkephalin more than rat endothelial cells. Transplanted rat chromaffin cells were stained with anti-TH antibody in striatum of mouse after 2 weeks. Pain sensitivity was reduced on the chromaffin cell-transplanted mouse compared to endothelial cell-transplanted mouse by the hot plate test. CONCLUSION: These results suggest that the rat chromaffin cells were suitably transplanted into the CNS of mouse. This approach could be used as a therapy for reducing of chronic pain induced by cancer or neuronal injury.


Asunto(s)
Animales , Ratones , Ratas , Catecolaminas , Células Cromafines , Cromatografía Líquida de Alta Presión , Dolor Crónico , Células Endoteliales , Encefalina Leucina , Encefalina Metionina , Encefalinas , Inmunohistoquímica , Neuronas , Tirosina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA